Ornithine decarboxylase (ODC) is a key regulatory enzyme in the biosynthesis of polyamines which are essential for normal cell growth and differentiation. The applicants have demonstrated that elevated levels of ODC and polyamines cooperate with a mutated Ha-ras gene to promote epithelial tumor formation and invasion. The applicant's hypothesis is that elevated levels of ODC and polyamines """"""""activate"""""""" keratinocytes and dermal stromal cells to produce a phenotype similar to that in wounded skin, which is characterized by increased proliferation and migration, neoangiogenesis, altered differentiation, and increased expression of proteases. A corollary is that conditions (or oncogenes) that sustain this polyamine-induced activation of cells will result in the development of a tumor. The overall goal of this project is to identify downstream effectors that play a key role in mediating ODC-promoted tumorigenesis in skin. The objective is complicated when tumors arise as a consequence of a mutated ras (as is generally found in initiated skin) since multiple effector pathways contribute to Ras-mediated transformation of cells. Therefore, in order to achieve these goals, the applicant plans to dissect out the downstream effectors of polyamines as well as the downstream effectors of an activated ras that cooperate with ODC and polyamines to drive epithelial tumorigenesis. To this end, Dr, Gilmour proposes the following specific aims: 1. To determine if elevated levels of ODC and polyamines activate keratinocytes and dermal stromal cells in a manner similar to that in wounded skin, ODC will be expressed in both normal quiescent adult epidermis (using an inducible ODC transgenic mouse model), and in proliferative activated epidermis (abrading K6/ODC transgenic mouse skin). By controlling expression of ODC in either sedentary or activated keratinocytes, the applicants will evaluate this noninitiated (i.e. no mutated ras gene) skin for the induction of: A. a wound healing phenotype, and B. the formation of benign skin tumors dependent upon sustained ODC-induced activation of cells. 2. Using the inducible ODC transgenic mouse model, mRNA from ODC overexpressing skin will be compared with that from normal skin using representational difference analysis (RDA) and microarray approaches. Genes that are upregulated or downregulated by ODC will be evaluated for their role in mediating the tumorigenic and invasive effects of ODC when expressed with a mutated H-ras. 3. Dr. Gilmour will determine which downstream effectors of an activated Ha-Ras can cooperate with elevated levels of ODC and polyamines to convert epidermal cells to a malignant invasive phenotype. In particular, she plans to investigate possible cooperation between ODC and various partial function effector mutants of an activate Ha-Ras that specifically induce either the raf-1/ERK, RalGDS, or phosphoinostitie 3-OH kinase pathway.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA070739-07
Application #
6646451
Study Section
Chemical Pathology Study Section (CPA)
Program Officer
Poland, Alan P
Project Start
2000-09-05
Project End
2005-08-31
Budget Start
2003-09-01
Budget End
2005-08-31
Support Year
7
Fiscal Year
2003
Total Cost
$279,614
Indirect Cost
Name
Lankenau Institute for Medical Research
Department
Type
DUNS #
125797084
City
Wynnewood
State
PA
Country
United States
Zip Code
19096
Alexander, Eric T; Minton, Allyson; Peters, Molly C et al. (2017) A novel polyamine blockade therapy activates an anti-tumor immune response. Oncotarget 8:84140-84152
Hayes, Candace S; Shicora, Allyson C; Keough, Martin P et al. (2014) Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment. Cancer Immunol Res 2:274-85
Hayes, Candace S; DeFeo-Mattox, Karen; Woster, Patrick M et al. (2014) Elevated ornithine decarboxylase activity promotes skin tumorigenesis by stimulating the recruitment of bulge stem cells but not via toxic polyamine catabolic metabolites. Amino Acids 46:543-52
Gerhart, Jacquelyn; Hayes, Candace; Scheinfeld, Victoria et al. (2012) Myo/Nog cells in normal, wounded and tumor-bearing skin. Exp Dermatol 21:466-8
Keough, Martin P; Hayes, Candace S; DeFeo, Karen et al. (2011) Elevated epidermal ornithine decarboxylase activity suppresses contact hypersensitivity. J Invest Dermatol 131:158-66
Hayes, Candace S; Defeo, Karen; Dang, Hong et al. (2011) A prolonged and exaggerated wound response with elevated ODC activity mimics early tumor development. Carcinogenesis 32:1340-8
Muller, Alexander J; DuHadaway, James B; Chang, Mee Young et al. (2010) Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion. Cancer Immunol Immunother 59:1655-63
Hogarty, Michael D; Norris, Murray D; Davis, Kimberly et al. (2008) ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma. Cancer Res 68:9735-45
Wei, Gang; DeFeo, Karen; Hayes, Candace S et al. (2008) Elevated ornithine decarboxylase levels activate ataxia telangiectasia mutated-DNA damage signaling in normal keratinocytes. Cancer Res 68:2214-22
Gilmour, Susan K (2007) Polyamines and nonmelanoma skin cancer. Toxicol Appl Pharmacol 224:249-56

Showing the most recent 10 out of 23 publications